Annual SGA
$6.88 M
+$679.00 K+10.95%
December 31, 2023
Summary
- As of February 7, 2025, VCNX annual SGA is $6.88 million, with the most recent change of +$679.00 thousand (+10.95%) on December 31, 2023.
- During the last 3 years, VCNX annual SGA has fallen by -$524.00 thousand (-7.08%).
- VCNX annual SGA is now -7.08% below its all-time high of $7.41 million, reached on December 31, 2020.
Performance
VCNX SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly SGA
$1.44 M
-$651.00 K-31.15%
September 30, 2024
Summary
- As of February 7, 2025, VCNX quarterly SGA is $1.44 million, with the most recent change of -$651.00 thousand (-31.15%) on September 30, 2024.
- Over the past year, VCNX quarterly SGA has dropped by -$356.00 thousand (-19.83%).
- VCNX quarterly SGA is now -31.15% below its all-time high of $2.09 million, reached on June 30, 2024.
Performance
VCNX Quarterly SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM SGA
-$1.39 B
-$18.58 M-1.36%
September 30, 2024
Summary
- As of February 7, 2025, VCNX TTM SGA is -$1.39 billion, with the most recent change of -$18.58 million (-1.36%) on September 30, 2024.
- Over the past year, VCNX TTM SGA has dropped by -$1.40 billion (-20071.13%).
- VCNX TTM SGA is now -641.47% below its all-time high of -$187.25 million.
Performance
VCNX TTM SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Selling, General & Administrative Expenses Formula
SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development
VCNX Selling, General & Administrative Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +10.9% | -19.8% | -10000.0% |
| 3 y3 years | -7.1% | -16.5% | -10000.0% |
| 5 y5 years | +49.0% | -16.5% | -10000.0% |
VCNX Selling, General & Administrative Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +10.9% | -31.1% | +1.8% | -18.8% | at low |
| 5 y | 5-year | -7.1% | +10.9% | -31.1% | +1.8% | -45.9% | at low |
| alltime | all time | -7.1% | +55.3% | -31.1% | +55.6% | -641.5% | at low |
Vaccinex Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $1.44 M(-31.1%) | $6.96 M(-0.9%) |
| Jun 2024 | - | $2.09 M(+16.4%) | $7.01 M(+0.9%) |
| Mar 2024 | - | $1.79 M(+10.1%) | $6.95 M(+1.0%) |
| Dec 2023 | $6.88 M(+10.9%) | $1.63 M(+8.8%) | $6.88 M(+0.4%) |
| Sep 2023 | - | $1.50 M(-26.0%) | $6.85 M(+1.3%) |
| Jun 2023 | - | $2.03 M(+17.6%) | $6.77 M(+7.4%) |
| Mar 2023 | - | $1.72 M(+7.5%) | $6.30 M(+1.5%) |
| Dec 2022 | $6.20 M(-0.4%) | $1.60 M(+13.4%) | $6.20 M(+0.6%) |
| Sep 2022 | - | $1.41 M(-9.3%) | $6.16 M(-1.1%) |
| Jun 2022 | - | $1.56 M(-4.3%) | $6.23 M(-0.7%) |
| Mar 2022 | - | $1.63 M(+4.1%) | $6.28 M(+0.8%) |
| Dec 2021 | $6.23 M(-15.9%) | $1.56 M(+5.4%) | $6.23 M(-4.2%) |
| Sep 2021 | - | $1.48 M(-7.5%) | $6.51 M(-5.6%) |
| Jun 2021 | - | $1.60 M(+1.8%) | $6.89 M(-4.7%) |
| Mar 2021 | - | $1.58 M(-14.3%) | $7.23 M(-2.3%) |
| Dec 2020 | $7.41 M | $1.84 M(-1.7%) | $7.41 M(-1.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2020 | - | $1.87 M(-3.7%) | $7.49 M(+4.8%) |
| Jun 2020 | - | $1.94 M(+11.0%) | $7.15 M(+5.6%) |
| Mar 2020 | - | $1.75 M(-9.2%) | $6.77 M(+1.5%) |
| Dec 2019 | $6.67 M(+44.4%) | $1.93 M(+25.9%) | $6.67 M(+8.9%) |
| Sep 2019 | - | $1.53 M(-2.0%) | $6.12 M(+7.7%) |
| Jun 2019 | - | $1.56 M(-5.1%) | $5.68 M(+12.6%) |
| Mar 2019 | - | $1.65 M(+19.3%) | $5.04 M(+9.2%) |
| Dec 2018 | $4.62 M(+3.0%) | $1.38 M(+26.5%) | $4.62 M(+6.5%) |
| Sep 2018 | - | $1.09 M(+18.1%) | $4.34 M(+1.2%) |
| Jun 2018 | - | $925.00 K(-24.2%) | $4.29 M(-7.5%) |
| Mar 2018 | - | $1.22 M(+11.1%) | $4.63 M(+3.4%) |
| Dec 2017 | $4.48 M(+1.2%) | $1.10 M(+5.7%) | $4.48 M(+32.5%) |
| Sep 2017 | - | $1.04 M(-18.4%) | $3.38 M(+44.4%) |
| Jun 2017 | - | $1.27 M(+19.1%) | $2.34 M(+119.1%) |
| Mar 2017 | - | $1.07 M | $1.07 M |
| Dec 2016 | $4.43 M | - | - |
FAQ
- What is Vaccinex annual SGA?
- What is the all time high annual SGA for Vaccinex?
- What is Vaccinex annual SGA year-on-year change?
- What is Vaccinex quarterly SGA?
- What is the all time high quarterly SGA for Vaccinex?
- What is Vaccinex quarterly SGA year-on-year change?
- What is Vaccinex TTM SGA?
- What is the all time high TTM SGA for Vaccinex?
- What is Vaccinex TTM SGA year-on-year change?
What is Vaccinex annual SGA?
The current annual SGA of VCNX is $6.88 M
What is the all time high annual SGA for Vaccinex?
Vaccinex all-time high annual SGA is $7.41 M
What is Vaccinex annual SGA year-on-year change?
Over the past year, VCNX annual SGA has changed by +$679.00 K (+10.95%)
What is Vaccinex quarterly SGA?
The current quarterly SGA of VCNX is $1.44 M
What is the all time high quarterly SGA for Vaccinex?
Vaccinex all-time high quarterly SGA is $2.09 M
What is Vaccinex quarterly SGA year-on-year change?
Over the past year, VCNX quarterly SGA has changed by -$356.00 K (-19.83%)
What is Vaccinex TTM SGA?
The current TTM SGA of VCNX is -$1.39 B
What is the all time high TTM SGA for Vaccinex?
Vaccinex all-time high TTM SGA is -$187.25 M
What is Vaccinex TTM SGA year-on-year change?
Over the past year, VCNX TTM SGA has changed by -$1.40 B (-20071.13%)